Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001780030-26-000005

Chief Financial Officer bought 15,641 shares at an average $25.65 ($401,269)

From the SEC's structured data for this filing

Trades in this filing

STEPHENSON BRIAN C · Chief Financial Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-24 Purchase : show line 1 in the form +2,891 $25.22 $72,911 20,304 I
2026-06-24 Purchase : show line 2 in the form +3,000 $25.98 $77,940 23,304 I
2026-06-24 Purchase : show line 3 in the form +3,400 $26.98 $91,732 26,704 I
2026-06-24 Purchase : show line 4 in the form +100 $27.77 $2,777 26,804 I
2026-06-26 Purchase : show line 5 in the form +580 $23.61 $13,694 27,384 I
2026-06-26 Purchase : show line 6 in the form +4,212 $24.90 $104,879 31,596 I
2026-06-26 Purchase : show line 7 in the form +1,358 $25.55 $34,697 32,954 I
2026-06-26 Purchase : show line 8 in the form +100 $26.39 $2,639 33,054 I
Open-market purchases · 15,641 sh · avg $25.65 · $401,269
Loading xslF345X06/form4-06262026_110625.xml…